Share

Search your stocks

Ctrl+K

Hamps Bio Ltd.Hamps Bio Ltd.

22.05(+5.00%)

1W: -0.99%

1M: -64.41%

1Y: -

Hamps Bio Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong demand in the manufacturing sector.
Operating margin improved by 5%, showcasing better cost management and operational efficiency.
Net income increased by 20%, reflecting effective pricing strategies and market expansion.

NEGATIVES

Raw material costs rose by 10%, impacting profitability despite revenue growth.
Debt levels increased, raising concerns about financial leverage and future interest obligations.
Sales volume in key markets showed stagnation, suggesting potential market saturation challenges.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-